Permanent Pacemaker Implantation After TAVI and Its Association with Survival: Single-Center Cohort and Nationwide Validation
Recent Publication
A current study led by the Department of Internal Medicine 3 at St. Pölten University Hospital is investigating whether a pacemaker influences survival after TAVI treatment. The results show that a newly inserted pacemaker after the procedure has no negative impact on short- or long-term mortality. The situation is different for patients who already had a pacemaker before the treatment - they have a higher long-term risk. However, this increased risk is more likely to be related to existing heart disease than to the pacemaker itself. This publication is freely accessible thanks to open access funding from Karl Landsteiner University.
Lamm, G., Veraar, C., Höbart, P., Granner, M., Will, M., Schwarz, K., Nitsche, C., Mousavi, R. A., Auer, J., Ankersmit, H. J., Hammerer, M., Hoppe, U. C., & Mascherbauer, J. (2026). Permanent Pacemaker Implantation After TAVI and Its Association with Survival: Single-Center Cohort and Nationwide Validation. Journal of Clinical Medicine, 15(6), 2288. https://doi.org/10.3390/jcm15062288
OÄ Dr. Gudrun Lamm
Division of Internal Medicine 3 (University Hospital St. Pölten)
PD DDr. Cecilia Veraar
Division of Internal Medicine 2 (University Hospital St. Pölten)
Dr. Matthias Granner BSc
Division of Internal Medicine 3 (University Hospital St. Pölten)
OA Dr. Maximilian Will
Division of Internal Medicine 3 (University Hospital St. Pölten)
OA Dr. Konstantin Schwarz PhD
Division of Internal Medicine 3 (University Hospital St. Pölten)
Prim. Univ.-Prof. Dr. Julia Mascherbauer
Head of
Division of Internal Medicine 3 (University Hospital St. Pölten)